Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» earnings
earnings
Here's How Moderna Turned a Profit in Q1 Despite Its Sales Declining by 69%
Here's How Moderna Turned a Profit in Q1 Despite Its Sales Declining by 69%
Motley Fool
Moderna Therapeutics
earnings
Flag link:
Amylyx’s ALS drug Relyvrio generates $71.4M in Q1
Amylyx’s ALS drug Relyvrio generates $71.4M in Q1
Medical Marketing and Media
Amylyx Pharmaceuticals
ALS
earnings
Relyvrio
Flag link:
Takeda cuts 2 midstage GI assets including Crohn's hopeful in latest pipeline cleanup
Takeda cuts 2 midstage GI assets including Crohn's hopeful in latest pipeline cleanup
Fierce Biotech
Takeda
R&D
gene therapy
earnings
Crohn’s disease
Flag link:
Why Shares of MannKind Were Up Wednesday
Why Shares of MannKind Were Up Wednesday
Motley Fool
MannKind
earnings
United Therapeutics
Flag link:
Catalent Delays Earnings Call, Shaves $400M Off FY23 Guidance
Catalent Delays Earnings Call, Shaves $400M Off FY23 Guidance
BioSpace
Catalent
earnings
CDMOs
Flag link:
Cash-rich BioNTech broadens scope as COVID shot sales slide
Cash-rich BioNTech broadens scope as COVID shot sales slide
Yahoo/Reuters
BioNTech
earnings
vaccines
COVID-19
cancer
Flag link:
Biogen, Novartis, Sanofi Cull Candidates in Q1 Pipeline Reprioritizations
Biogen, Novartis, Sanofi Cull Candidates in Q1 Pipeline Reprioritizations
BioSpace
Biogen
Novartis
Sanofi
earnings
R&D
Flag link:
Novo Nordisk Q1 Earnings In Line, Sales Miss, View Up
Novo Nordisk Q1 Earnings In Line, Sales Miss, View Up
Yahoo/Zacks.com
Novo Nordisk
earnings
Flag link:
Revenues down for Moderna, up for Regeneron in Q1
Revenues down for Moderna, up for Regeneron in Q1
Medical Marketing and Media
Moderna Therapeutics
Regeneron
earnings
Flag link:
As Amgen's revenues slide, so too do sales at its big buyout target Horizon
As Amgen's revenues slide, so too do sales at its big buyout target Horizon
Fierce Pharma
Amgen
earnings
Horizon Therapeutics
Flag link:
Zimmer Biomet reports top- and bottom-line growth as orthopedic procedures return
Zimmer Biomet reports top- and bottom-line growth as orthopedic procedures return
Medtech Dive
Zimmer Biomet
earnings
Medtech
Flag link:
Pfizer reports strong Q1 earnings, including $18.3B in revenues
Pfizer reports strong Q1 earnings, including $18.3B in revenues
Medical Marketing and Media
Pfizer
earnings
COVID-19
vaccines
Paxlovid
Flag link:
Analyst ‘blown away’ by robot-fueled growth of Stryker’s hip and knee sales
Analyst ‘blown away’ by robot-fueled growth of Stryker’s hip and knee sales
Medtech Dive
Medtech
earnings
Stryker
Mako Surgical
Flag link:
Amgen cuts lupus programs for futility, hours after Lilly officially walks away from one too
Amgen cuts lupus programs for futility, hours after Lilly officially walks away from one too
Fierce Biotech
Amgen
earnings
Eli Lilly
lupus
Flag link:
Merck beats first-quarter expectations on Keytruda, Gardasil strength
Merck beats first-quarter expectations on Keytruda, Gardasil strength
Reuters
Merck
earnings
Flag link:
Q1 revenues slide for Amgen, Gilead
Q1 revenues slide for Amgen, Gilead
Medical Marketing and Media
Amgen
Gilead Sciences
earnings
Flag link:
Sanofi, after $8B outlay, sees M&A strategy deliver 2 more duds
Sanofi, after $8B outlay, sees M&A strategy deliver 2 more duds
Fierce Biotech
Sanofi
M&A
earnings
Ablynx
Principia Biopharma
Flag link:
Roche’s new eye drug pressures Eylea with strong launch
Roche’s new eye drug pressures Eylea with strong launch
BioPharma Dive
Roche
Vabysmo
Eylea
earnings
Regeneron
Flag link:
Novartis Culls 10% of Pipeline, Doubles Down on Five Core Therapeutic Areas
Novartis Culls 10% of Pipeline, Doubles Down on Five Core Therapeutic Areas
BioSpace
Novartis
earnings
solid tumors
hematology
immunology
Neuroscience
cardiovascular disease
Flag link:
Roche, seeing MAGE magic wane, makes pair of solid tumor bispecifics disappear
Roche, seeing MAGE magic wane, makes pair of solid tumor bispecifics disappear
Fierce Biotech
Roche
earnings
solid tumors
MAGE-A4
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »